Literature DB >> 18042489

Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies.

Olga K Baryshnikova1, Monica X Li, Brian D Sykes.   

Abstract

The cardiac-specific N-terminus of cardiac troponin I (cTnI) is known to modulate the activity of troponin upon phosphorylation with protein kinase A (PKA) by decreasing its Ca(2+) affinity and increasing the relaxation rate of the thin filament. The molecular details of this modulation have not been elaborated to date. We have established that the N-terminus and the switch region of cTnI bind to cNTnC [the N-domain of cardiac troponin C (cTnC)] simultaneously and that the PKA signal is transferred via the cTnI N-terminus modulating the cNTnC affinity toward cTnI(147-163) but not toward Ca(2+). The K(d) of cNTnC for cTnI(147-163) was found to be 600 microM in the presence of cTnI(1-29) and 370 microM in the presence of cTn1(1-29)PP, which can explain the difference in muscle relaxation rates upon the phosphorylation with PKA in experiments with cardiac fibers. In the light of newly found mutations in cNTnC that are associated with cardiomyopathies, the important role played by the cTnI N-terminus in the development of heart disorders emerges. The mutants studied, L29Q (the N-domain of cTnC containing mutation L29Q) and E59D/D75Y (the N-domain of cTnC containing mutation E59D/D75Y), demonstrated unchanged Ca(2+) affinity per se and in complex with the cTnI N-terminus (cTnI(1-29) and cTnI(1-29)PP). The affinity of L29Q and E59D/D75Y toward cTnI(147-163) was significantly perturbed, both alone and in complex with cTnI(1-29) and cTnI(1-29)PP, which is likely to be responsible for the development of malfunctions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042489     DOI: 10.1016/j.jmb.2007.10.062

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  The heart-specific NH2-terminal extension regulates the molecular conformation and function of cardiac troponin I.

Authors:  Shirin Akhter; Zhiling Zhang; J-P Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 2.  Protein phosphorylation and signal transduction in cardiac thin filaments.

Authors:  R John Solaro; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

Review 3.  Cardiac myosin binding protein-C: a structurally dynamic regulator of myocardial contractility.

Authors:  Natosha L Finley; Tzvia I Cuperman
Journal:  Pflugers Arch       Date:  2014-01-28       Impact factor: 3.657

4.  A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding.

Authors:  David Dweck; Daniel P Reynaldo; Jose R Pinto; James D Potter
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

Review 5.  Integration of troponin I phosphorylation with cardiac regulatory networks.

Authors:  R John Solaro; Marcus Henze; Tomoyoshi Kobayashi
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

6.  Significance of troponin dynamics for Ca2+-mediated regulation of contraction and inherited cardiomyopathy.

Authors:  Devanand Kowlessur; Larry S Tobacman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

7.  Challenging current paradigms related to cardiomyopathies. Are changes in the Ca2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes?

Authors:  David Dweck; Nir Hus; James D Potter
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

8.  S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.

Authors:  Tomoya Irie; Patrick Y Sips; Shinichi Kai; Kotaro Kida; Kohei Ikeda; Shuichi Hirai; Kasra Moazzami; Pawina Jiramongkolchai; Donald B Bloch; Paschalis-Thomas Doulias; Antonis A Armoundas; Masao Kaneki; Harry Ischiropoulos; Evangelia Kranias; Kenneth D Bloch; Jonathan S Stamler; Fumito Ichinose
Journal:  Circ Res       Date:  2015-08-10       Impact factor: 17.367

Review 9.  Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies.

Authors:  Athanasia Kalyva; Fragiskos I Parthenakis; Maria E Marketou; Joanna E Kontaraki; Panos E Vardas
Journal:  J Muscle Res Cell Motil       Date:  2014-04-18       Impact factor: 2.698

10.  The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium.

Authors:  Axel Neulen; Robert Stehle; Gabriele Pfitzer
Journal:  Basic Res Cardiol       Date:  2009-06-09       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.